What Is Mounjaro?
Mounjaro (tirzepatide) is a once-weekly prescription injection used for weight management in adults. Originally developed to treat type 2 diabetes, it is now approved in the UK as a medical treatment for obesity and overweight conditions.
It works differently from older medications by targeting two key appetite and metabolic hormones:
- GLP-1 (glucagon-like peptide-1)
- GIP (glucose-dependent insulinotropic polypeptide)
This dual mechanism is what sets Mounjaro apart from other weight loss injections such as Wegovy (semaglutide), which targets only GLP-1.
How Mounjaro Works in the Body
Mounjaro helps regulate appetite and energy intake through multiple pathways:
- Slows stomach emptying — you feel full for longer
- Reduces hunger signals in the brain
- Improves blood sugar control
- Reduces cravings, especially for high-calorie foods
The result: most people naturally eat less without strict dieting. The dual GLP-1 and GIP action is believed to produce a stronger combined appetite-suppressing effect than a single-hormone approach, as evidenced by the SURMOUNT-1 clinical trial.
Clinical Results: How Much Weight Can You Lose?
Clinical trials show significant weight loss outcomes when combined with lifestyle support. Average results from the SURMOUNT-1 trial published in the New England Journal of Medicine:
These findings are supported by studies published in journals such as the New England Journal of Medicine. Results vary by individual, dosage, and lifestyle adherence. Use our BMI calculator to understand what these percentages mean in absolute terms for your weight.
Mounjaro vs Other Weight Loss Injections
Mounjaro is often compared with other GLP-1-based treatments available in the UK. The key difference is Mounjaro's dual-hormone mechanism:
| Treatment | Frequency | Average Weight Loss |
|---|---|---|
| Mounjaro (tirzepatide) | Weekly | 15–22% |
| Wegovy (semaglutide) | Weekly | 12–15% |
| Saxenda (liraglutide) | Daily | 5–10% |
Key difference: Mounjaro targets two hormones instead of one, which may lead to stronger results for some patients. However, individual response varies—see our full Wegovy vs Mounjaro comparison and Mounjaro vs Saxenda comparison for a detailed breakdown.
Who Can Get Mounjaro in the UK?
Eligibility follows clinical guidelines aligned with organisations like the National Institute for Health and Care Excellence (NICE). You may qualify if:
- BMI ≥ 30
- BMI ≥ 27 with a related condition such as type 2 diabetes, high blood pressure, or sleep apnoea
Not suitable for:
- History of pancreatitis
- Certain thyroid conditions
- Pregnancy or breastfeeding
A consultation with a licensed clinician is required before any prescription can be issued. You can use our BMI calculator to check your BMI before booking a consultation. See our guide on how long it takes to get Mounjaro for what to expect after eligibility is confirmed.
Side Effects of Mounjaro
Most side effects are mild and improve over time as your body adjusts to the medication. The NHS tirzepatide page and the official SmPC provide full side effect information.
- Common: nausea, digestive discomfort, fatigue
- Less common but serious: pancreatitis, gallbladder issues
Always follow guidance from your clinician. If you experience severe or persistent abdominal pain, seek medical advice promptly.
Cost of Mounjaro in the UK
Prices vary depending on provider and dosage. Typical factors affecting cost:
- Clinic or pharmacy — verified providers vary in their pricing structure.
- Dose level — higher doses typically cost more per pen.
- Availability and demand — stock constraints can affect pricing.
NHS access is limited and usually restricted to specialist weight management programmes. For private prescriptions, use our Mounjaro price comparison tool to find the lowest verified prices from GPhC-registered pharmacies. You can also compare cheapest GLP-1 options across all treatments.
Is Mounjaro Worth It?
Pros
- ✓Higher average weight loss compared to other GLP-1 treatments
- ✓Once-weekly injection — easier to maintain than daily medications
- ✓Supports long-term appetite control beyond the initial phase
- ✓Dual-hormone mechanism may be more effective for those with insulin resistance
Considerations
- →Ongoing private cost — NHS access is currently restricted
- →Requires lifestyle changes to maximise and sustain results
- →Possible side effects, particularly gastrointestinal, especially early in treatment
- →Requires ongoing clinical supervision and prescription renewal
Mounjaro represents a significant advancement in medical weight loss treatment in the UK. Its dual-hormone mechanism and strong clinical outcomes make it one of the most effective options currently available. Whether it is right for you depends on your individual health profile, eligibility, and access to a prescribing clinician.
Related Guides
Sources & Further Reading
This guide references the following official and authoritative sources.
- 1Mounjaro (tirzepatide) SmPC — electronic Medicines Compendium
Official UK prescribing reference for Mounjaro, including mechanism of action, clinical data, and safety information.
- 2SURMOUNT-1 Trial — New England Journal of Medicine
Phase 3 randomised controlled trial demonstrating tirzepatide's weight loss outcomes of up to 22.5% body weight loss.
- 3NHS — Tirzepatide (Mounjaro)
NHS information on tirzepatide including side effects, dosing, and important patient safety advice.
- 4NICE — Obesity: identification, assessment and management (CG189)
NICE clinical guideline providing the evidence base for BMI thresholds and weight management treatments in the UK.
- 5MHRA — Tirzepatide approved for weight management in the UK
MHRA approval documentation for tirzepatide (Mounjaro) as a treatment for obesity and overweight in UK adults.
- 6Compare Mounjaro prices UK — Health Wise
Verified price comparison for Mounjaro across GPhC-registered UK pharmacies, updated regularly.
Frequently Asked Questions
How quickly does Mounjaro work?
Many users notice appetite changes within the first few weeks, but significant weight loss typically develops over several months. Clinical trials show the most rapid losses in months 1–3, with continued but slower progress through month 12.
Is Mounjaro better than other injections?
It may produce greater average weight loss due to its dual-hormone action targeting both GLP-1 and GIP receptors, but suitability depends on individual health factors. A clinician will assess whether Mounjaro, Wegovy, or Saxenda is most appropriate for you.
Can I get Mounjaro without a prescription?
No. Mounjaro is a prescription-only medication regulated in the UK by the MHRA. It must be prescribed by a registered clinician following an appropriate consultation and eligibility assessment.
Does Mounjaro work differently from Wegovy?
Yes. Wegovy (semaglutide) targets only GLP-1 receptors, while Mounjaro (tirzepatide) targets both GLP-1 and GIP receptors. This dual action is believed to contribute to Mounjaro's higher average weight loss outcomes in clinical trials.
How much does Mounjaro cost in the UK?
Private costs vary by dose level and provider. NHS access is currently limited to specialist weight management programmes. Our price comparison tool shows the latest verified prices from GPhC-registered pharmacies.
